Stereotaxis is trading at $0.95, down 5.81%, with no clear reason identified for the decline.
- No October 19 company-specific headline was found; Schwab reported no Stereotaxis headlines for that date, and the company’s listed results release was from August 11.
- The supplied market context was broadly positive and does not explain the decline.
- Earlier analyst target reductions and quarterly revenue shortfalls are background, not a confirmed October 19 catalyst.